Stock Groups

Novozymes reports Q4 operating profit below estimates -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – Containers seen in the enzyme factory at Novozymes, a Danish biopharmaceutical firm in Beijing (China), May 24, 2011 REUTERS/David Gray/File Photo

COPENHAGEN (Reuters – Novozymes, an enzyme manufacturer reported a fourth quarter operating loss slightly below its expectations on Tuesday. However, it said that sales are expected to increase organically by 3-7% over the following financial year.

According to the Danish company, fourth quarter earnings before tax and interest were 805 million Danish crowns (121.60 millions). This is lower than an 844 million average forecasted by Refinitiv analysts.

($1 = 6.6200 Danish crowns)

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]